Third, since sonography was only performed in participants with elevated serum ALT or CHB, many participants with NAFLD might have a normal ALT and be classified as the unaffected group, possibly underestimating the risk of incident MetS with CHB. The gene discussed is GPT; the disease is metabolic syndrome.